• Obacunone Induces Ferroptosis in Ovarian Cancer via Akt/p53

  2026-05-06

  This study demonstrates that obacunone, a citrus-derived compound, induces ferroptosis in ovarian cancer cells by modulating the Akt/p53 signaling pathway. The research supports ferroptosis as a relevant therapeutic target in ovarian cancer and highlights the utility of selective inhibitors such as Ferrostatin-1 (Fer-1) for mechanistic studies.

• Toremifene vs Tamoxifen: Cochrane Review Insights for SERMs

  2026-05-05

  This Cochrane review rigorously compares toremifene and tamoxifen in the management of advanced breast cancer, evaluating efficacy and safety endpoints across multiple randomized trials. The findings inform selective estrogen receptor modulator (SERM) development and translational strategies in both oncology and bone health research.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Binding

  2026-05-05

  Oliveira et al. (2025) reveal that naturally occurring angiotensin peptide fragments, including N-terminally truncated forms, significantly enhance the binding of the SARS-CoV-2 spike protein to the alternative receptor AXL. This mechanistic insight bridges cardiovascular peptide biology and viral pathogenesis, highlighting new molecular interactions with implications for both COVID-19 and blood pressure regulation research.

• G418 Sulfate (Geneticin): Precision Selection & Antiviral Po

  2026-05-04

  Geneticin (G-418 Sulfate) delivers robust, high-fidelity cell selection and unique antiviral capabilities for modern molecular workflows. This guide details protocol enhancements, troubleshooting, and strategic insight, leveraging APExBIO’s ultra-pure formulation for reproducible results in genetic engineering and virology.

• IL-17A Drives Corpus Cavernosum Fibrosis via mTORC2-ACACA in

  2026-05-04

  Yang et al. identify IL-17A as a key driver of smooth muscle senescence and fibrosis in neurogenic erectile dysfunction, acting through the mTORC2-ACACA pathway. The study clarifies mechanistic links between inflammation, cellular aging, and fibrotic remodeling, providing new targets for therapeutic intervention.

• Nelfinavir Mesylate: Benchmark HIV-1 Protease Inhibitor for

  2026-05-03

  Nelfinavir Mesylate is a potent, orally bioavailable HIV-1 protease inhibitor with nanomolar efficacy and a robust clinical safety profile. It is validated for HIV replication suppression and emerging as a tool for mechanistic studies in regulated cell death, such as ferroptosis. This article provides evidence-backed parameters and clarifies domain boundaries for translational research.

• PEGylation Enhances Targeted Delivery of LAF–Xenopeptide mRN

  2026-05-02

  This study demonstrates how PEGylation improves the colloidal stability and targeting precision of LAF–xenopeptide mRNA polyplexes, overcoming key barriers in non-viral mRNA delivery. The findings provide a mechanistic basis for optimizing nanoparticle formulation and ligand-mediated targeting in translational gene delivery applications.

• Dlin-MC3-DMA: Ionizable Cationic Liposome for RNA Delivery S

  2026-05-01

  Dlin-MC3-DMA is setting the benchmark as an ionizable cationic liposome for siRNA and mRNA delivery, offering orders-of-magnitude improvements in potency and tolerability. This article unpacks how to design lipid nanoparticle workflows, optimize gene silencing, and troubleshoot formulation bottlenecks using this APExBIO-supplied lipid.

• USP36-Snail1 Axis Drives Ribosome Biogenesis Under Ribotoxic

  2026-05-01

  This study uncovers how the USP36-Snail1 pathway stabilizes nucleolar Snail1, thereby enhancing ribosome biogenesis and promoting cancer cell survival under ribotoxic stress. These findings provide a mechanistic rationale for combining ribosome inhibitors with targeted blockade of the JNK-USP36-Snail1 axis to improve therapeutic efficacy against solid tumors.

• Curcumin Modulates ISC Differentiation via Wnt/β-Catenin in

  2026-04-30

  This study demonstrates that curcumin alleviates dextran sulfate sodium-induced ulcerative colitis in mice by inhibiting the Wnt/β-catenin signaling pathway and restoring intestinal stem cell (ISC) differentiation. These mechanistic insights advance the understanding of curcumin’s therapeutic potential in mucosal healing and targeted intervention in chronic colitis.

• Antibody-Based Inhibition of CD16 Shedding Enhances ADCC in

  2026-04-30

  This study introduces F9H4, a monoclonal antibody that selectively inhibits the shedding of CD16a and CD16b from immune effector cells, thereby enhancing antibody-dependent cellular cytotoxicity (ADCC) against tumors. The findings provide a substrate-targeted solution to augment Fcγ receptor-mediated anti-tumor responses while avoiding the pleiotropic effects of broad-spectrum protease inhibitors.

• Gentamycin Sulfate in Bacterial Ribosome Fidelity and Resist

  2026-04-29

  Explore the profound role of Gentamycin Sulfate as an aminoglycoside antibiotic in dissecting ribosomal fidelity and resistance mechanisms. This article offers an advanced perspective on assay optimization and translational research, bridging molecular insight with practical application.

• Gentamycin Sulfate: Unlocking Advanced Bacterial Protein Syn

  2026-04-29

  Gentamycin Sulfate stands as a cornerstone aminoglycoside antibiotic for dissecting bacterial protein synthesis, ribosome function, and antibiotic resistance in Gram-negative models. This article delivers actionable workflows, protocol enhancements, and troubleshooting strategies—anchored in the latest evidence—to empower robust, reproducible research using APExBIO’s high-purity reagent.

• Nanoplastics and Cadmium Co-exposure Triggers Intestinal Apo

  2026-04-28

  This study uncovers how simultaneous exposure to polystyrene nanoplastics and cadmium accelerates apoptosis in intestinal cells via the IP3R/Ca2+/STAT3 pathway. These mechanistic insights highlight the importance of calcium chelation strategies for dissecting toxicant-induced cell signaling and inform environmental risk assessment.

• BI 2536: PLK1 Inhibitor for G2/M Arrest and Cancer Research

  2026-04-28

  BI 2536, a potent and selective PLK1 inhibitor, has redefined the precision of cell cycle regulation assays and apoptosis studies in cancer research. APExBIO’s reference-grade reagent enables robust, reproducible workflows from in vitro screening to in vivo xenograft modeling, while the latest mechanistic insights empower researchers to probe mitotic checkpoint control with unprecedented clarity.

8066 records 14/538 page Previous Next First page 上5页 1112131415 下5页 Last page